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CHAPTER 11 
Ethics, Efficacy, and Decision-making in Animal 
Research 
Lawrence A. Hansen 
Professor of Pathology, University of California, San Diego, United States 
Kori Ann Kos berg 
University of California, San Diego, United States 
kosberg@me.com 
1 Introduction 
The true rule in determining to embrace or reject anything is not whether 
it has any good in it, but whether it has more of evil than of good. Few 
things are wholly evil or wholly good. Almost everything is a composite of 
the two, so that our best judgement of the predominance between them 
is continually demanded. 
ABRAHAM LINCOLN,June 20, 18481 in a speech to the United States (us) House 
of Representatives on Internal Improvements, suggesting an approach to decision 
making in ethically complex situations 
Few would disagree with the ethical contention that if cruelty to animals is 
not wrong, then nothing is wrong. In fact, it is not only wrong, but in most 
states in the us, it is a crime, a felony no less. And yet, intentionally inflicting 
pain and suffering upon animals, which meets Webster's definition of cruelty, 
is routinely countenanced when vivisection (from the Latin vivi, to be alive, 
and secare, to cut) is performed under license for biomedical research. Decid­
ing to embrace, or reject, or limit animal research demands our best ethical 
judgment; and it is complicated by factual disputes over the extent to which 
it benefits human health. Three issues combining facts and ethics need to be 
considered. First, to what extent does animal research deliver on its promise 
to improve human health? Second, if the goal of public investment ( e.g., tax 
dollars spent by the National Institute of Health, NIH) on animal research is to 
improve human health, are we getting sufficient return for the billions spent, 
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or might the money be better directed towards human-based research or im­
plementing healthcare interventions of proven efficacy? Third, since opinions 
about ends justifying means will vary, who should decide if animal research is 
ethically justified: the scientists who perform it or representatives of the public 
at large, who pay for it? 
In the us, the biomedical academic research establishment, as currently 
constituted, empowers animal researchers to determine what animal experi­
mentation is allowed. But this represents an obvious conflict of interest, since 
the researchers' livelihoods depend on continuing animal use, and their atti­
tudes about the ethical justifications for vivisection are a priori set in stone, as 
evidenced by their career choices. Shifting the ethical paradigm about animal 
experimentation will require transferring decision-making authority about an­
imal use in science from the animal researchers who carrying out experiments 
to the public who finances them and who may be less inclined to approve any 
and all use of animals in experimentation. 
2 To What Extent Does Animal Research Improve Human Health? 
It is axiomatic, even reflexive, for proponents of animal research to contend 
that virtually every medical achievement of the last century has depended directly 
or indirectly on research with animals. But it may be wise to consider the source 
of such a sweeping proclamation. The quotation traces back to a 1994 article in 
The Physiologist, a journal heavily invested in publishing animal research, enti­
tled "The importance of animals in biomedical and behavioral research" where 
it appears as a bold assertion unaccompanied by any substantiating evidence 
(Matthews, 2008, p. 95). Does this claim bear up under empirical scrutiny in 
the modern era of evidence-based medicine? 
A recently published summary of systematic reviews investigating the rel­
evance of animal based research to human medicine (Pound and Bracken, 
2014) provides a comprehensive consideration of the topic. The authors con­
clude that animal research is plagued by poor quality, typically fails to address 
internal and external validity, lacks randomization and blinding, engages in 
selective analysis and outcome reporting, and suffers from publication bias, 
all resulting in overstatements about the validity of entire bodies of research. 
An even more exhaustively referenced review article on the use of animals in 
medical science research cites multiple studies documenting the failure of ani­
mal models to translate into human benefit in HIV/AIDS, stroke, cancer, spinal 
cord injury, traumatic brain injury, cardiovascular disease, diabetes, and meno­
pausal hormonal therapy (Pippin, 2013). A prescient earlier analysis by Crowley 
in 2003 (Sung et al., 2003) had already established that out that of 25,000 basic 
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research articles published in the top 6-ranked joumals for basic research, only 
one was associated with a clinically useful new drug in 30 years of publica­
tion. The dismal track record of animal research leading to improved human 
health has been succinctly summarized in yet another study (Tsilidis et al., 
2013) reviewing data from the Collaborative Approach to Meta-Analysis and Re­
view of Animal Data.from Experimental Studies, which concludes that bias in 
animal studies makes it nearly impossible to rely on most animal data to pre­
dict whether or not an intervention will have a favorable clinical benefit-risk 
ratio in human subjects. 
Poor study design contaminated by bias doubtlessly contributes to the ir­
relevance of most animal research to medical progress. But a deeper, fatal flaw 
in the entire animal research paradigm may be its assumption that evolution­
ary continuity between humans and other animals allows valid cross-species 
extrapolation, essentially a presupposition that what we learn to be true in 
one species will be true in another (Ioannidis, 2012 ). Evolutionary continuity 
can account for the success of animal model extrapolations early in the his­
tory of physiology, as when William Harvey, a seminal figure in the develop­
ment of medicine and physiology, correctly deduced the closed-circuit nature 
of human blood flow after observing it in non-human animals. But that was 
in 1628; in the modem era of personalized medicine, when patients' tumors 
are characterized with chromosomal scanning and cancer gene panels to 
identify specific mutations directing individualized chemotherapy, the no­
tion that mice represent furry pocket-sized models of humans seems scien­
tifically quaint. Non-human animals are not simplified versions of humans, as 
the word model implies, but are rather evolved systems, differently complex 
in their own right. Small differences in initial conditions of a complex system, 
such as diverging regulation and expression of genes, modifier genes, or post­
translational protein processing can result in two superficially similar systems 
(human and non-human animals), exhibiting vastly different responses to the 
same experimental manipulations (Greek and Shanks, 2009). 
If forced to concede by meta-analyses that most animal experimentation 
bears no clinical fruit, animal researchers defend it by arguing that its crit­
ics are insufficiently appreciative of the contributions made by vivisection to 
our cumulative fund of biomedical knowledge ( Carbone, 2012 ), not only as a 
curiosity-driven, fact-finding quest for knowledge, but as it applies to the un­
derstanding and progression of human disease. This argument justifies animal 
research as basic rather than applied science. How can opponents of ani­
mal research ever know that in the fullness of time an insight into basic biology 
derived from an animal experiment of no relevance to human health, at the 
time it was performed, might not, someday, be important to improving health? 
This rhetorical contention is nebulous enough to be impossible to refute, since 
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no one knows the future. Any and all research is justified by this argument, 
and it implies that no ethical balancing of pain and suffering cost to experi­
mental animals against the expectation of human health gain should even be 
attempted. Basic research that uses animals will continue to find new facts 
about basic biology, as it has in the past. But to conflate finding new facts with 
advances in human health as ethical justification for animal research is a dis­
ingenuous bait and switch. 
3 What Is the Cost to Benefit Ratio of Spending on Animal Research 
to Improve Health? 
Dawning awareness of the failure of most animal based research to benefit hu­
man health is reflected in commentary from the current and a former head of 
the NIH, the agency in charge of funding biomedical research in the us, with 
a us$39 billion budget in 2019 (NIH, 2019). Francis Collins, the present head of 
the NIH, wrote, "The use of animal models for therapeutic development and 
target validation is time consuming, costly, and may not accurately predict effi­
cacy in humans. As a result, many clinical compounds are carried forward only 
to fail in phase II or phase III clinical trials: many others are probably aban­
doned because of the shortcomings of the [animal] model" ( Collins, 2011, p. 
3). Concerning the same failure of animal models, a former NIH director, Elias 
Zerhouni, commented more memorably, "We have moved away from studying 
human disease in humans. We all drank the Kool-Aid on that one [ transgenic 
mouse models], me included [ ... ] The problem is that it hasn't worked, and 
it's time we stopped dancing around the problem [ ... ] We need to refocus and 
adapt new methodologies for use in humans to understand disease biology in 
humans" (McManus, 2013). 
Among such innovative new methodologies for studying human diseases 
in humans are organotypic cultures that combine cellular constituents to 
replicate entire tissues and tumor environments, allowing cellular, subcellu­
lar, and molecular biological experiments historically performed on animals 
to instead be conducted on the species of interest - humans. Bacterial pro­
duction of insulin has replaced its traditional extraction from bovine or swine 
pancreas, and chromatography is used to determine drug purity and dosage 
rather than animal usage (Doke and Dhawale, 2015). Human stem cells are an­
other modern research modality being utilized to study human diseases and 
develop drugs to combat them. Experimental techniques converging on the 
goal of personalized medicine include pharmacogenomics and genetic (gene 
chip) microarrays. These wet bench innovations are complimented by ad­
vanced non-invasive imaging methods, such as positron emission tomography, 
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accelerator mass spectroscopy, and magnetic resonance imaging. These and 
many other human-species relevant research methods may be far more likely 
than discredited animal models to advance health. 
Proponents of animal research often invoke the ultimate goal of reducing 
human disease morbidity and mortality as justification for the pain and suffer­
ing inherent in animal experimentation. In truth, however, if that is the goal, 
then from a global health perspective, we would be getting a much better re­
turn on healthcare investment by sparing the animals and spending the money 
on soap and hand-washing. Every year, respiratory infections and diarrhea kill 
more than 3.5 million children under the age of 5, and that death toll could 
be cut in half simply with soap and hand-washing. One study found 50% less 
pneumonia and 53°/o fewer cases of diarrhea in families given soap and encour­
aged to wash their hands (Luby et al., 2005). A meta-analysis of similar studies 
of diarrhea alone concluded that hand washing reduced its incidence by 42%-
4 7°/o, and that promoting hand washing could save a million lives a year ( Curtis 
and Carincross, 2003). No one expects the us research establishment to redi­
rect any of its funding toward hand washing in the cause of global healthcare 
or health justice, since the lives to be saved are outside the us. Nevertheless, 
ethical justification for animal research, as a means for improving human 
health, should be viewed with some skepticism when far more directly effec­
tive, less expensive, and ethically unproblematic means for saving millions of 
children's lives are immediately at hand but underutilized because of spending 
priorities. 
4 When Is Animal Research Stewardship and When Is It Despotism? 
Stewardship is the careful and responsible management of something en­
trusted to one's care. The concept has Judea-Christian roots but has acquired a 
secular meaning in an environmental context, embraced by many with no re­
ligious faith at all. Originally, stewardship was an obligation imposed upon hu­
mankind by God, when granting humanity dominion over the rest of creation. 
As is often the case with the exercise of power, this dominion of humans over 
animals has not worked to the animals' advantage. For millennia, the prevail­
ing human ethos has been instrumentalism, the belief that animals exist for us, 
to serve our interests and wants. This attitude stems from moral anthropocen­
trism, the conviction that humans, set above animals by divine edict, should 
always have absolute priority in our moral reasoning about animal use. While 
thisJudeo-Christian tradition has been hard on animals, at least in theory, obli­
gations of stewardship accompanying dominion should temper our treatment 
of animals even as we use them for our own ends. 
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The concept of stewardship persists in altered form, as society has become 
progressively less religious and more secular, challenging traditional assump­
tions about humanity's divinely ordained special status in creation. The fact of 
human dominion remains, even if attributed to evolutionary happenstance, 
and is recognized in an atheist scientific worldview, now often expressed by 
the term homocene or anthropocene to describe a human dominated natural 
world (Schwager! and Crutzen, 2014). A secularized version of stewardship 
endures too, transformed into an ethical environmentalism in which our ob­
ligation is to preserve the ecological habitability of the planet we inherited 
for future generations to enjoy. One ramification of ecological rather than reli­
gious stewardship is the recognition that humans are part of rather than over 
and above the rest of nature. As Darwin initially observed, and subsequent 
evolutionary biology has confirmed, human and non-human animals are fun­
damentally more alike than dissimilar (Darwin, 1859 ). Beyond shared biology, 
behavioral research shows that many animals exhibit traits once presumed 
to be uniquely human, including sympathy, empathy, cooperation, a sense of 
fairness and justice, and a very humanlike capacity for future oriented cogni­
tion (Roberts, 2012 ). The privileged moral status humans continue to assign 
ourselves is ethically arbitrary and self-serving, more an example of humans 
as rationalizing than rational creatures, enlisting our intellectual nimbleness 
in the service of our desires. 
Animal researchers should consider themselves doubly obligated by a con­
temporary secular sense of stewardship. First, society pays for what they do; 
and the poor translation of most animal research into human health benefits, 
which is what the public thinks that it is buying, is a failure of financial steward­
ship. Second, stewardship in a secular scientific age requires a rebalancing of 
the ethical scales we use in determining what kind of animal use is justifiable. 
Science informs us that animals are sentient beings like ourselves, capable of 
pleasure and pain ( Griffin and Speck, 2004 ). They are not just property or tools; 
they have their own interior life deserving of respect. If a more highly sophis­
ticated capacity for ethical reasoning and morality is what sets humans apart 
from other animals, then ethical reasoning and morality must always guide us 
in how we treat them. Cruel basic science, rather than medically relevant ex­
periments performed on empathy-inspiring species, may seem to be the easy 
case to make against animal research as poor ethical stewardship. Neverthe­
less, decades of protests, focused on such seemingly easy cases to make, have 
not, for example, stopped neurophysiological visual tracking research on Rhe­
sus macaques in which they undergo coil implants in both eyes, holes drilled 
into their skulls for recording electrode placements, and head immobiliza­
tion surgeries in which screws, plates, and bolts are implanted in their heads. 
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Following these procedures, the monkeys are dehydrated to provide, what the 
researchers call, a "work ethic", so that they will visually track a moving object 
for a sip of water reward, while tied into a restraining chair with their heads 
bolted into an immobilizing frame. First impressions are accurate in recog­
nizing animal cruelty, and most of us cannot even bear to look at pictures of 
these monkeys with bolted heads and electrode-implanted brains being put 
through their paces in a desperate attempt to get a life sustaining sip of water; 
but despite ethical revulsion to an easy case of animal cruelty, this research has 
continued for decades (Ramachandran and Lisberger, 2005); and cats, another 
favored species, are being treated similarly (Yartsev, 2009 ), as well as mice ( Guo 
et al., 2014). Making animals suffer this intensely, in pursuit of a basic science 
research agenda, merely because we can, because we have the power of total 
control over them, is more despotism than stewardship. "Might makes right" is 
not an ethical argument. 
5 Who Decides if Ends Justify Means in the Ethics of Animal 
Research? 
Animal researchers occupy one end of an ethical opinion spectrum. They 
have concluded that the hypothetical expanding of scientific knowledge justi­
fies the means they employ, and that the suffering inflicted on experimental 
animals is acceptable in the pursuit of a greater good. At the opposite pole 
are animal rights activists, who believe that cruelty to animals is wrong, pe­
riod, and that no scientific ends can justify means that entail animal pain 
and suffering. Public opinion polling informs us that most people occupy an 
ethical middle ground, with approval of animal research contingent upon 
animals not suffering too much, and only in the service of research likely to 
benefit human health. 51% of Americans believe medical testing on animals 
is morally acceptable (Jones, 2017); and 65% of the United Kingdom public 
supports medical testing in the absence of an alternative model ( Clemence 
and Leaman, 2016). People also express different attitudes towards animal 
use, depending on the species involved, and are less supportive of research 
using dogs, cats, and non-human primates than of research with mice, rats, 
and fish (Ormandy and Schuppli, 2014). 48% of people in the UK believe it is 
acceptable to use rats in medical research to benefit people, while only 16% 
approve of using dogs (Clemence and Leaman, 2016). So, how are these ethical 
differences arbitrated in academic research centers at present? And who gets 
to decide, in specific instances of proposed animal use, if the end justifies the 
means? 
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In the us, federal laws and regulations that govern animal use in research 
stem from public outrage over cruelty to animals destined for research labora­
tories exposed in a LIFE magazine article in 1966, which prompted the us Con­
gress to pass the Laboratory Animal Welfare Act. Subsequently renamed the 
Animal Welfare Act (Aw A), and repeatedly amended in the decades since, it is 
administered by the Department of Agriculture (USDA). A 1985 AWA amend­
ment and the Health Research Extension Act, also passed in 1985 and adminis­
tered under Public Health Service (PHS) Policy on Humane Care and Use of 
Laboratory Animals rules, both mandated the establishment of Institutional 
Animal Care and Use Committees (1Acucs) at all facilities performing bio­
medical research on animals (Levin and Reppy, 2015). Minimum IACUC mem­
bership requirements, initially set forth in the AWA, balanced public bioethical 
concerns and scientific expertise, stipulating a three-member committee to 
include a laboratory animal veterinarian, a committee chair, and one mem­
ber who is not affiliated in any way with the institution and is not an animal 
user, who would represent general community interests in the treatment of 
animals. The minimum PHS IACUC requirements were similarly balanced, 
stipulating a minimum of five persons, including an institutional laboratory 
veterinarian, an animal researcher, a member unaffiliated with the institution, 
and a member whose primary concern was not in the scientific arena ( e.g., an 
ethicist, lawyer, or clergy member) (Hansen, 2013). 
The founding directives for IACUC memberships would have created IACUCs 
that reflected public concern for laboratory animal welfare and performed 
ethical cost-benefit analyses of proposed animal research, with approval con­
tingent upon a balancing of animal pain and suffering against a reasonable 
expectation of resultant human benefit. However, institutions heavily incen­
tivized by grant funding attached to animal research realized that the USDA 
and PHS dictates for IACUC membership were only minimum requirements 
which did not limit the numbers of additional animal researchers who could 
be appointed to the committees, tipping their balance to ensure approval of 
all animal research protocols. They also recognized that, unlike the European 
Union Directive instituted to address the same bioethical issues in animal re­
search (Directive 2010/63/EU, European Parliament, 2010 ), neither of the two 
us regulatory requirements set for IACUCs specifically mandated an ethical 
review of animal research protocols prior to their authorization (Levin and 
Reppy, 2015). 
Consequently, expanded IACUCs now averaging 23 members rather than 
three or five, are heavily skewed towards animal researchers ( 67%) and insti­
tutional veterinarians whose livelihoods depend on animal research ( 15% ), 
and 93°/o of IACUC chairs are animal researchers (Hansen, 2013). Predictably, 
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IAcucs in which 82% of members and 93% of chairs have vested interests 
in continuing animal research approve essentially all proposed animal experi­
ments set before them. 98% of proposed animal experiments are approved 
according to the most comprehensive analysis available (Pious and Herzog, 
2001), without considering an ethical balancing of animal harm against hu­
man health gain. An expert on how IACUCs function, and a longtime defender 
of the system, writes plainly, "Few people realize that virtually nothing is pro­
hibited by the Animal Welfare Act, so long as it can be justified to the IACUC. 
Nor do IACUCs, by and large, function by rejecting animal protocols when the 
ethical costs are too high [ . . .  ] [R]ejection of protocols is not what IACUCs do 
[ . . .  ] [E]ven painful animal experiment may be allowed [ . . .  ] any research proto­
col may be approved [ . . .  ] regardless of any weighing of the potential benefits" 
(Carbone, 2004). 
This institutionalized blanket endorsement of all animal use disregards the 
public's attitude of contingent approval of animal research, heavily qualified by 
concerns over limiting suffering, promises of resultant disease treatments, and 
avoidance of experimentation on favored species, i.e. dogs, cats, and primates 
(Henry and Roarke, 2009; Swami, Furnah, and Christopher, 2008). An example 
IACUC ruling from the University of California, San Diego (ucso ), in 2001, il­
lustrates how disconnected the system is from public bioethics. Hundreds 
of San Diego physicians signed an anti-dog lab petition, urging the Medical 
School to end dog vivisection and euthanasia teaching exercises in a freshman 
pharmacology course. These physicians knew from professional experience 
that killing dogs was unnecessary in becoming a doctor and so filed an appeal 
to the ucso IACUC, pointing to PHS guidelines requiring a good-faith effort to 
replace animal labs in education and research, once alternatives became avail­
able. The signatories to the anti-dog lab petition reasoned that since 95% of 
schools taught the course without killing dogs (Hansen and Boss, 2002 ), it must 
be unnecessary for ucso to do so. The official response of the ucso IACUC 
was that vivisection and euthanasia of dozens of dogs in those labs raised no 
animal welfare issues. This seemed like Orwellian newspeak to the doctors, and 
public protests followed. Finally, after sufficient adverse publicity, the ucso 
Faculty Council and School of Medicine Department Chairs ended the un­
necessary dog vivisections, accomplishing what the IACUC should have done 
years before; that is, "respect society's concerns regarding the welfare of animal 
subjects" (Hansen, 2013, p. 188), as was stipulated in the AWA amendment of 
1985, creating the IACUC system. 
So, the answer to the question, who decides if ends justify means in the ethics 
of animal research? is-animal researchers. But the word decide is misleading 
in this context, if it is taken to imply the result of a deliberative process that 
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could have more than one outcome, as when a jury decides to acquit or con­
vict a defendant. The animal researcher dominated IACUCs have determined 
a priori that experimental animals are of so little ethical worth compared to 
the value they place on hypothetically increasing scientific knowledge that the 
ends always justify the means. Decisions from committees of wolves arbitrat­
ing the fate of sheep would be less predictable. 
6 How Could Research Ethics Be Better Aligned with Public Concern 
for Animal Welfare? 
The IACUC system fails to address ethical issues in animal research which are 
of concern to the public, because it is dominated by those whose livelihoods, 
careers, and professional identities are dependent upon the unfettered con­
tinuation of animal experimentation. It is asking too much of human nature 
to expect that committees of animal researchers could set aside their conflicts 
of interest, inclination to groupthink, and conscious and unconscious biases 
to look at the ethics of animal use in research as does society at large. Ethi­
cal constraints on how animals are treated in research have always been ex­
ternally imposed on an, oftentimes, resistant biomedical establishment. The 
latter's ingenuity in evading such constraints is seen not only in its stacking 
of the IACUC membership deck with animal researchers, but also by its suc­
cessful lobbying effort to amend the AWA in 2002, so as to exclude from its 
protections mice and rats who comprise 99% of the animals used in research 
laboratories (Farm Security and Rural Investment Act, 2002 ). Even the few fa­
vored species of greatest ethical concern to the public, i.e. primates, dogs, and 
cats, supposedly covered by the nominal protections of the AWA, are routinely 
subject to medically irrelevant basic science experimentation, which most 
people would consider cruelty, if it were performed on themselves or their pet 
dogs or cats. 
Two possible solutions to the disconnect between society's nuanced and 
qualified attitude towards animal research and the IAcuc's philosophy of 
"anything goes" are worth considering, both of which would work towards 
achieving the paradigm shift in ending animal experimentation. First, the AWA 
could be amended to restore its initially intended balance between researchers 
and members representing societal interest in animal welfare. A second more 
definitive approach would be a legal ban on research using primates, dogs, 
and cats, leaving researchers with 99% of the animals they are using currently, 
and respecting the public's ethical qualms about the suffering of their favored 
species. One precedent for how protecting favored species may succeed is the 
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constraint recently imposed on chimpanzee research by the NIH, in response 
to a report from the Institute of Medicine Committee on the Necessity of the 
Use of Chimpanzees in Biomedical and Behavioral Research (Kahn, 2014). If 
one species of non-human animals can be set off limits to vivisection, solely 
because of ethical concerns, it raises hopes that others may follow, which is 
why the constraints were so strongly opposed by animal researchers not us­
ing chimpanzees, fearing this precedent may be the thin edge of an ethical 
wedge. As for legally banning companion animal research, the fact that in 2014 
Americans spent over us$50 billion on their dogs and cats may indicate that 
there is a deep, yet untapped, reservoir of potential political support for such 
legislation. 
7 Summary and Conclusions 
Paradigm shifts in science occur when new theories make more accurate and 
reproducible predictions than old ones about empirically observed natural phe­
nomena or experimental results. When the term paradigm shift is applied to the 
ethics of animal experimentation, the concept becomes less scientifically lit­
eral, and understanding how ethically seismic paradigm shifts occur in human 
history is challenging. Once they have occurred, however slow their incubation, 
they are codified into laws reflecting an altered ethical consensus. Slavery was 
once legal, now it is not; women now have equality under the law with men, but 
through most of human history they did not. Changing the ethical paradigm 
about animal experimentation requires both a scientific analysis of its lack of ef­
ficacy in improving human health, and an ethical appeal to broaden our sphere 
of compassion for our fellow sentients. If successful, such a paradigm change will 
ultimately outlaw any animal experimentation that causes pain and suffering. 
From a purely scientific perspective, multiple meta-analyses indicate that 
animal based research only rarely translates into improved human health. This 
failure of to benefit human health can result from poor study design as well as 
intrinsic evolutionary differences, precluding the extrapolation of results from 
one species to another; but regardless of its cause, this failure undercuts a major 
ethical justification for inflicting harm on animals in biomedical research. NIH 
directors past and present recognize the low yield of animal research in ben­
efitting human health and recommend shifting funding priorities towards new 
methodologies for use in humans to understand disease biology in humans (Mc­
Manus, 2013). From a global healthcare perspective, and considering the ethics 
of healthcare justice, money spent on basic science animal research, if diverted 
to implementing healthcare interventions of proven efficacy, could save many 
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millions more human lives. Legal constraints were imposed on animal research 
by us Congress in response to public outrage over exposes of animal abuse, re­
sulting in the Laboratory Animal Welfare Act in 1966 and the mandated creation 
of IAcucs in 1985 to address public concerns about laboratory animal welfare. 
However, IACUCs, as currently constituted, are dominated by animal research­
ers who have determined, a priori, to approve any and all use of animals in 
biomedical research, without regard to public ethical concerns about limiting 
animal suffering, which species are used, and relevance to human health. 
Because animal researchers now control the use of animals in experimenta­
tion, any paradigm change will require wrestling authority away from them and 
investing it in a broader range of ethical stakeholders, specifically the public 
and its elected representatives who are more inclined than career vivisectors 
to weigh the ethical cost to human benefit of animal experimentation. The ban 
on chimpanzee vivisection, despite the opposition of animal experimenters, 
may represent a template for moral progress toward the hoped-for paradigm 
shift. If public empathy for our fellow primates can overcome the resistance 
of the biomedical academic establishment to banning chimpanzee research, 
it is cause for optimism that a similar approach to other favored species, such 
as dogs and cats, may generate an ethical momentum, like falling dominoes, 
towards finally expanding the circle of human compassion to encompass all 
creatures capable of pain and suffering. 
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